三一生物科技 TRIB 深 沪
已收盘 03-27 16:00:00 美东时间
0.601
-0.012
-2.04%
华盛通- 最 高0.64
- 今 开0.60
- 成交量 17.30万股
- 最 低 0.5998
- 昨 收 0.6135
- 总市值 1124.49万
- 52周最高 3.44
- 市盈率 静 --
- 换手率 0.92%
- 52周最低 0.48
- 委 比 93.55%
- 总股本 1871.03万
- 历史最高 139.20
- 量 比 0.78
- 振 幅 6.55%
- 历史最低 0.48
- 每 手 1
- 风险率 0.24%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Trinity Biotech Announces Successful Clinical Test Results For New Prostate Cancer Test AI-Incorporated Algorithm
The performance of the upgraded test was evaluated in a comprehensive clinical study involving approximately 750 patient samples, representing a substantially larger and more ethnically diverse cohort than EpiCapture's
03-23 21:26
Trinity Biotech Expects Q4 Revenue Range ~$11.5M - $12.5M
Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced an update on its trading
03-10 19:51
Trinity Biotech Receives Nasdaq Noncompliance Notice
Trinity Biotech plc (NASDAQ:TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, received notice on February 11, 2026 from the
02-14 06:12
Trinity Biotech Obtains Full Regulatory Approval For The Commencement Of Upstream Manufacturing Activities For Its Flagship WHO Prequalified Uni-Gold HIV Rapid Test Under The Company's Offshored And Outsourced Production Model
Trinity Biotech plc (NASDAQ:TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced it has now received full
02-11 02:33
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Trinity Biotech (NASDAQ:TRIB) stock moved upwards by 54.7% to $1.38 du...
2025-12-24 01:05
Why Is Trinity Biotech Stock Soaring Tuesday?
Trinity Biotech (NASDAQ: TRIB) surged on Tuesday due to a large HIV testing order and balance-sheet restructuring.
2025-12-23 22:59
Trinity Biotech shares are trading higher after the company announced it was awarded an order for 9 million TrinScreen HIV tests.
Trinity Biotech shares are trading higher after the company announced it was aw...
2025-12-23 20:34
Trinity Biotech Expands Global Rollout Of Next-Generation HbA1c Column System
Company advances its mission to deliver next-generation diabetes management solutions and expand global market penetrationNext-generation column technology enhances efficiency, expands recurring revenue potential, and
2025-12-15 22:19
Trinity Biotech Partners With Unnamed Bioinformatics Firm To Conduct Analysts On Clinical Study Data For EpiCapture Epigenetic Liquid Biopsy Test To Monitor Prostate Cancer
Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced a strategic collaboration with a
2025-11-14 22:06
Trinity Biotech Welcomes Perceptive Advisor’s Indication of Potential Debt-to-Equity Conversion - Strengthening Balance Sheet and Supporting Growth
Trinity Biotech plc announced that its largest investor, Perceptive Advisors, plans to propose converting部分 debt into equity, aiming to strengthen the company's financial position and support its growth objectives. Perceptive Advisors has been a supportive partner during Trinity Biotech's transformation. The company期待通过这一 initiative 增强财务灵活性并实现其增长目标。
2025-10-27 13:00
